A recent study has provided a new understanding of how cannabidiol (CBD) reduces seizures, especially in people with treatment-resistant epilepsy.
The new study led by researchers at NYU Grossman School of Medicine was published in Neuron.
- A study at NYU Grossman School of Medicine has tested the impact of CBD, the non-euphoric component of cannabis.
- Researchers confirmed a previous discovery that CBD impacts the nerve signals in the hippocampus, the brain area associated with epilepsy.
- The study's findings have further increased CBD's value as an anticonvulsant treatment.
- The study explained how CBD prevents seizures and how circuits are balanced in the brain, said Richard Tsien, chair of the Department of Physiology and Neuroscience at NYU Langone Health.
- Imbalances exist in other conditions, including autism and schizophrenia, making the study potentially broader.
